{"id":"sm-1","safety":{"commonSideEffects":[{"rate":"null","effect":"Pneumonitis"},{"rate":"null","effect":"Hypothyroidism"},{"rate":"null","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"SM-1 works by binding to the PD-1 receptor, preventing its interaction with its ligand PD-L1, and thereby enhancing T-cell activation and proliferation. This leads to an increase in anti-tumor immune response.","oneSentence":"SM-1 is a small molecule that targets the PD-1 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:35:02.787Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic non-small cell lung cancer, PD-L1 positive"},{"name":"Metastatic melanoma"}]},"trialDetails":[{"nctId":"NCT06385717","phase":"","title":"Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-05-01","conditions":"Esophagus Cancer","enrollment":120},{"nctId":"NCT03338764","phase":"PHASE3","title":"An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia","status":"WITHDRAWN","sponsor":"Sequential Medicine Ltd","startDate":"2023-05","conditions":"Transient Insomnia","enrollment":""},{"nctId":"NCT06218108","phase":"","title":"Multicenter Observational Study Taulí-T1 Classification for the Management of pT1 Rectal Adenocarcinoma","status":"UNKNOWN","sponsor":"Corporacion Parc Tauli","startDate":"2023-10-02","conditions":"Rectal Cancer Stage I","enrollment":317},{"nctId":"NCT04780230","phase":"NA","title":"Non-invasive Brain Stimulation to Enhance Treatment of Dysarthria Post-stroke","status":"COMPLETED","sponsor":"The Hong Kong Polytechnic University","startDate":"2020-12-21","conditions":"Dysarthria, Stroke","enrollment":3},{"nctId":"NCT05497362","phase":"NA","title":"Non-invasive Brain Stimulation as a Treatment for Dysarthria Post-stroke","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2016-04-01","conditions":"Dysarthria, Stroke","enrollment":9},{"nctId":"NCT05445193","phase":"NA","title":"PEaters Choice™: Nutrition Intervention Module for Picky Eaters","status":"UNKNOWN","sponsor":"National University of Malaysia","startDate":"2023-03","conditions":"Picky Eating","enrollment":154},{"nctId":"NCT04396327","phase":"PHASE2","title":"SM-1 vs. an Active Comparator in A Model of Transient Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Sequential Medicine Ltd","startDate":"2020-05-27","conditions":"Transient Insomnia","enrollment":14},{"nctId":"NCT03331042","phase":"PHASE3","title":"SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.","status":"COMPLETED","sponsor":"Sequential Medicine Ltd","startDate":"2017-10-09","conditions":"Transient Insomnia","enrollment":85},{"nctId":"NCT02671760","phase":"PHASE2","title":"Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia","status":"COMPLETED","sponsor":"Sequential Medicine Ltd","startDate":"2016-02","conditions":"Short-term Insomnia","enrollment":39},{"nctId":"NCT03424655","phase":"NA","title":"Post-endodontic Pain After Single-visit Root Canal Treatment","status":"COMPLETED","sponsor":"Jorge Paredes Vieyra","startDate":"2017-11-12","conditions":"Relate Post-endodontic Pain","enrollment":224}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"SM-1","genericName":"SM-1","companyName":"Sequential Medicine Ltd","companyId":"sequential-medicine-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SM-1 is a small molecule that targets the PD-1 receptor. Used for Metastatic non-small cell lung cancer, PD-L1 positive, Metastatic melanoma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}